A Treatment for ED That Actually Fixes the Problem.
Drug-free. Non-invasive. Designed to restore natural blood flow. May be covered by Medicare for qualifying patients.
Book Confidential Consultation Call 817-329-0102
Also used by teams across the NFL, NBA, MLB, NHL, PGA, and UFC for recovery.
Per SoftWave manufacturer-published reports of institutional and professional team use.
Pills Don't Fix ED. They Mask It.
Oral ED medications work by temporarily increasing blood flow when you take them. They don't address the underlying vascular issue. When the pill wears off, the problem comes back.
Low-intensity shockwave therapy takes a different approach. It's designed to stimulate the body's natural repair process in penile blood vessels, working toward improvement that doesn't depend on a pill in your pocket.
How SoftWave Works
Acoustic energy is delivered to the targeted area in a series of short, painless pulses. The waves are intended to stimulate growth of new blood vessels and break up micro-plaque in existing ones, supporting natural blood flow.
Each session takes about 15 minutes. No needles, no surgery, no drugs, no downtime. Walk in, get treated, go on with your day. Most clinical protocols involve a series of treatments over 3 to 6 weeks; your physician will tailor the plan to your case.
Backed by Real Science, Not Marketing Hype
Low-intensity shockwave therapy is one of the most researched non-pharmaceutical options being studied for erectile dysfunction. Multiple sham-controlled randomized trials have reported measurable improvement on validated scoring systems.
IIEF-5 Improvement vs. Sham
A 2019 meta-analysis of 10 sham-controlled randomized trials (873 men) reported an average IIEF-5 score improvement of about 4 points over sham treatment.
Sokolakis & Hatzichristodoulou, 2019. Int J Impot Res.Erection Hardness Odds
A 2026 updated meta-analysis pooled 18 randomized trials and 1,180 men. Odds of achieving an erection hardness score of 3 or better were 4.78× higher with shockwave than sham at one month.
You et al., 2026. J Sex Med.Vasculogenic ED
A 2025 meta-analysis specifically of 12 randomized trials in vasculogenic ED (882 men) found significant improvements in erectile function scores compared to sham.
Future Sci OA, 2025.A 2026 systematic review and meta-analysis in The Journal of Sexual Medicine pooled 18 randomized controlled trials covering 1,180 men with ED. Across studies, low-intensity shockwave therapy produced clinically meaningful improvements in erectile function scores and erection hardness compared to sham treatment.
You H et al. (2026). J Sex Med. PubMed via OUP.This Treatment May Be Covered by Medicare
SoftWave is covered by Original Medicare (Parts A & B) for qualifying patients. If you have a Medicare supplement, your copay is usually taken care of too.
Original Medicare (A & B)
Covered for qualifying patients. Medicare supplement covers your copay. Most patients pay $0 out of pocket.
Medicare Advantage
Most Advantage plans don't cover this treatment. Affordable cash-pay rates available. Same FDA-cleared device, same physician.
Off-Label Disclosure
SoftWave is FDA-cleared for blood circulation and connective tissue. Use for ED is off-label and discussed openly during your consultation.
Your Privacy Matters
All consultations are completely confidential. We treat men's health concerns every day in a professional, judgment-free environment. Your visit stays between you and your physician.
Meet Your Physician
Dr. Abdullah is board-certified in internal medicine and certified in hormone therapy through the Hormonal Health Institute. He treats men's health conditions including low testosterone and ED at Magnolia Functional Wellness in Southlake.
He also serves as a clinical instructor at UT Southwestern Medical Center and assistant professor at TCU/UNTHSC, where he trains the next generation of physicians.
You're not getting a technician or a corporate chain. You're getting a physician who actually treats you.
Pick a Time That Works for You
All appointments are confidential. Choose a time below.
Prefer to talk first? Call 817-329-0102